VGM Petitions CMS to Consider Repercussions Dealt by Manufacturing Surcharges

Published in Government Relations on September 09, 2021

Of the many negative byproducts instituted by the pandemic, manufacturing surcharges emerge as one of the largest expenditures currently being incurred. The supply chain continues to be impacted, passing down higher acquisition costs to providers. Providers cannot pass this cost onto their patients and incur unexpected costs to their businesses while being at the mercy of reimbursement rates CMS dictates. These surcharges do not adjust immediately in response to industry variables. These excessive costs are another burden thrown on the pile in our struggling industry along with labor costs, delivery costs, and unsustainable reimbursement.

We have heard suppliers’ pleas for help and guidance. Acknowledging this, VGM sent a letter to CMS asking for consideration to combat this continual cost. You can read the letter here. If you have any questions, reach out to Emily Harken at Emily.harken@vgm.com or at 319.830.1578.


TAGS

  1. cms
  2. covid-19
  3. phe
  4. reimbursement
  5. vgm government

From Our Experts

Williams Brothers Healthcare Hosts Meet-and-Greet Event with Rep. Erin Houchin thumbnail Williams Brothers Healthcare Hosts Meet-and-Greet Event with Rep. Erin Houchin Last week, Williams Brothers Healthcare organized a meet-and-greet event featuring Representative Erin Houchin (R-IN-9) to address crucial topics related to HME services and the challenges faced by providers. OMEPA's Legislative Triumphs: A Tale of Relationships and Persistence thumbnail OMEPA's Legislative Triumphs: A Tale of Relationships and Persistence Over the past few legislative sessions, Oklahoma Medical Equipment Providers Association (OMEPA) has navigated a legislative rollercoaster. Their commitment to building relationships and advocating for patients has led to significant wins. Audit Climate – Taking The Temperature thumbnail Audit Climate – Taking The Temperature As we near the midpoint of 2024, what are the main billing/reimbursement headaches being faced by providers? [Vlog] Oxygen Policy Update thumbnail [Vlog] Oxygen Policy Update Listen in as Ronda Buhrmester clarifies the language of the oxygen policy around the co-signature that is highly recommended. Elimination of Noncompete Agreements - FTC Final Rule thumbnail Elimination of Noncompete Agreements - FTC Final Rule A 570-page final rule released by the FTC on April 23 will effectively put an end to the use of noncompete agreements between employers and employees. The final rule is scheduled for publication in the Federal Register on May 7, 2024, and will go into effect 120 days from publication (September 4, 2024), barring the results of any legal challenges to the rule. OMEPA Celebrates Another Successful Capitol Rally Day thumbnail OMEPA Celebrates Another Successful Capitol Rally Day On April 23, OMEPA members gathered at the Oklahoma Capitol in support of HB1712. Government Relations: Speak With One Voice thumbnail Government Relations: Speak With One Voice The DMEPOS industry must show a unified front, speak with a unified voice, and together be champions of change. Clarification on Standard Written Orders thumbnail Clarification on Standard Written Orders Recently the DME MACs released a Dear Physician Letter that clarified language on a standard written order (SWO) specifically related to CPAP masks. While the article was great news being welcomed by the industry, it also initiated additional conversation for other PAP supplies such as interfaces and tubing.